Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$442,821
+$1,994 QoQ
Shares Held
3,505
+10.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,435
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST POINT INC. holds $18,783,056 across 10 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,181 | $6,395,217 | |
| 2 | LLY |
ELI LILLY & Co
|
2,996 | $3,593,491 | |
| 3 | ABBV |
AbbVie Inc.
|
10,133 | $2,549,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,851 | $1,908,353 | |
| 5 | PFE |
Pfizer Inc
|
67,683 | $1,629,806 | |
| 6 | NVS |
Novartis AG
|
6,344 | $994,231 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,912 | $801,609 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,505 | $442,821 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,821 | 3,505 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $440,827 | 3,163 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $382,212 | 3,114 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $338,106 | 3,046 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $502,351 | 4,531 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $340,183 | 3,036 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $389,154 | 4,213 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $339,048 | 4,044 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $238,694 | 3,479 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $279,668 | 3,818 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $364,626 | 4,501 | Shares | Sole | 2024-01-23 | |
| No filing history on record for this holder in this stock. | ||||||